TERCONAZOLE Drug Patent Profile
✉ Email this page to a colleague
When do Terconazole patents expire, and when can generic versions of Terconazole launch?
Terconazole is a drug marketed by Fougera Pharms, Fougera Pharms Inc, Taro, and Padagis Israel. and is included in seven NDAs.
The generic ingredient in TERCONAZOLE is terconazole. There are six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the terconazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Terconazole
A generic version of TERCONAZOLE was approved as terconazole by TARO on April 6th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TERCONAZOLE?
- What are the global sales for TERCONAZOLE?
- What is Average Wholesale Price for TERCONAZOLE?
Summary for TERCONAZOLE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 7 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Clinical Trials: | 8 |
| Patent Applications: | 4,678 |
| Drug Prices: | Drug price information for TERCONAZOLE |
| What excipients (inactive ingredients) are in TERCONAZOLE? | TERCONAZOLE excipients list |
| DailyMed Link: | TERCONAZOLE at DailyMed |
Recent Clinical Trials for TERCONAZOLE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hatem AbuHashim | N/A |
| Assiut University | Phase 3 |
| Curatek Pharmaceuticals, LLC | Phase 3 |
Pharmacology for TERCONAZOLE
| Drug Class | Azole Antifungal |
Anatomical Therapeutic Chemical (ATC) Classes for TERCONAZOLE
US Patents and Regulatory Information for TERCONAZOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fougera Pharms | TERCONAZOLE | terconazole | CREAM;VAGINAL | 076712-001 | Feb 18, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Taro | TERCONAZOLE | terconazole | SUPPOSITORY;VAGINAL | 077553-001 | Mar 9, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Taro | TERCONAZOLE | terconazole | CREAM;VAGINAL | 075953-001 | Apr 6, 2004 | BX | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fougera Pharms Inc | TERCONAZOLE | terconazole | CREAM;VAGINAL | 021735-001 | Oct 1, 2004 | BX | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Taro | TERCONAZOLE | terconazole | CREAM;VAGINAL | 076043-001 | Jan 19, 2005 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
